Travis Osterman

Drs. Shaalan Beg and Travis Osterman discuss a new machine learning model that uses electronic health record data to predict immune checkpoint inhibitor effectiveness and toxicity. The AI model can personalize risk-benefit profiles, inform treatment decisions, and enhance clinical trial selection. They delve into the significance of accurately identifying patients who benefit from treatment while avoiding adverse reactions.